|
2020 Journal Article Screening for anti-NMDAR encephalitis in psychiatryWarren, Nicola, Flavell, Joshua, O'Gorman, Cullen, Swayne, Andrew, Blum, Stefan, Kisely, Steve and Siskind, Dan (2020). Screening for anti-NMDAR encephalitis in psychiatry. Journal of Psychiatric Research, 125, 28-32. doi: 10.1016/j.jpsychires.2020.03.007 |
|
2020 Journal Article Evaluation of the proposed anti-N-Methyl-D-Aspartate receptor encephalitis clinical diagnostic criteria in psychiatric patientsWarren, Nicola, O’Gorman, Cullen, Blum, Stefan, Kisely, Steve, Swayne, Andrew, Flavell, Joshua and Siskind, Dan (2020). Evaluation of the proposed anti-N-Methyl-D-Aspartate receptor encephalitis clinical diagnostic criteria in psychiatric patients. Acta Psychiatrica Scandinavica, 142 (1), 52-57. doi: 10.1111/acps.13197 |
|
2020 Journal Article The clinical profile of NMOSD in Australia and New ZealandBukhari, Wajih, Clarke, Laura, O’Gorman, Cullen, Khalilidehkordi, Elham, Arnett, Simon, Prain, Kerri M., Woodhall, Mark, Silvestrini, Roger, Bundell, Christine S., Ramanathan, Sudarshini, Abernethy, David, Bhuta, Sandeep, Blum, Stefan, Boggild, Mike, Boundy, Karyn, Brew, Bruce J., Brownlee, Wallace, Butzkueven, Helmut, Carroll, William M., Chen, Celia, Coulthard, Alan, Dale, Russell C., Das, Chandi, Dear, Keith, Fabis-Pedrini, Marzena J., Fulcher, David, Gillis, David, Hawke, Simon, Heard, Robert ... Broadley, Simon A. (2020). The clinical profile of NMOSD in Australia and New Zealand. Journal of Neurology, 267 (5), 1431-1443. doi: 10.1007/s00415-020-09716-4 |
|
2019 Journal Article Psychiatric management of anti-NMDAR encephalitis: a cohort analysisWarren, Nicola, O'Gorman, Cullen, McKeon, Gemma, Swayne, Andrew, Blum, Stefan and Siskind, Dan (2019). Psychiatric management of anti-NMDAR encephalitis: a cohort analysis. Psychological Medicine, 51 (3) PII S0033291719003283, 1-6. doi: 10.1017/s0033291719003283 |
|
2019 Journal Article Serum and CSF anti-NMDAR antibody testing in psychiatryWarren, Nicola, Swayne, Andrew, Siskind, Dan, O'Gorman, Cullen, Prain, Kerri, Gillis, David and Blum, Stefan (2019). Serum and CSF anti-NMDAR antibody testing in psychiatry. The Journal of neuropsychiatry and clinical neurosciences, 32 (2), appineuropsych19030079-160. doi: 10.1176/appi.neuropsych.19030079 |
|
2019 Journal Article Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelinationTea, Fiona, Lopez, Joseph A., Ramanathan, Sudarshini, Merheb, Vera, Lee, Fiona X. Z., Zou, Alicia, Pilli, Deepti, Patrick, Ellis, van der Walt, Anneke, Monif, Mastura, Tantsis, Esther M., Yiu, Eppie M., Vucic, Steve, Henderson, Andrew P. D., Fok, Anthony, Fraser, Clare L., Lechner-Scott, Jeanette, Reddel, Stephen W., Broadley, Simon, Barnett, Michael H., Brown, David A., Lunemann, Jan D., Dale, Russell C., Brilot, Fabienne, Sinclair, Adriane, Kermode, Allan G., Kornberg, Andrew, Bye, Annie, McGettigan, Benjamin ... Blum, Stefan (Australasian and New Zealand MOG Study Group member) (2019). Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination. Acta Neuropathologica Communications, 7 (1) 145. doi: 10.1186/s40478-019-0786-3 |
|
2019 Journal Article Long-term follow-up of patients with myasthenia gravis treated with low-dose rituximabChan, Fiona, Swayne, Andrew, Gillis, David, Walsh, Michael, Henderson, Robert D., McCombe, Pamela A., Wong, Richard C. and Blum, Stefan (2019). Long-term follow-up of patients with myasthenia gravis treated with low-dose rituximab. Journal of Neurology, Neurosurgery and Psychiatry, 90 (8), 1-2. doi: 10.1136/jnnp-2018-319410 |
|
2019 Journal Article 084 Treating yourself: a glucocorticoid secreting tumour suppressing myasthenia gravis (vol 89, pg a34, 2018)Swayne, Andrew, Lane, Michael, Brown, Helen, Prain, Kerri, Wong, Richard, Gillis, David and Blum, Stefan (2019). 084 Treating yourself: a glucocorticoid secreting tumour suppressing myasthenia gravis (vol 89, pg a34, 2018). Journal of Neurology Neurosurgery and Psychiatry, 90 (4), E3-E3. doi: 10.1136/jnnp-2018-ANZAN.83corr1 |
|
2019 Journal Article Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra studyMielke, Orell, Bril, Vera, Cornblath, David R., Lawo, John-Philip, van Geloven, Nan, Hartung, Hans-Peter, Lewis, Richard A., Merkies, Ingemar S.J., Sobue, Gen, Durn, Billie, Shebl, Amgad, van Schaik, Ivo N., Sabet, A., George, K., Roberts, L., Carne, R., Blum, S., Henderson, R., Van Damme, P., Demeestere, J., Larue, S., D'Amour, C., Kunc, P., Valis, M., Sussova, J., Kalous, T., Talab, R., Bednar, M., Toomsoo, T. ... Gable, K. (2019). Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study. Journal of the Peripheral Nervous System, 24 (1), 72-79. doi: 10.1111/jns.12303 |
|
2019 Journal Article Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studiesMerkies, Ingemar S.J., van Schaik, Ivo N., Léger, Jean-Marc, Bril, Vera, van Geloven, Nan, Hartung, Hans-Peter, Lewis, Richard A., Sobue, Gen, Lawo, John-Philip, Durn, Billie L., Cornblath, David R., De Bleecker, Jan L., Sommer, Claudia, Robberecht, Wim, Saarela, Mika, Kamienowski, Jerzy, Stelmasiak, Zbigniew, Tackenberg, Björn, Mielke, Orell, Sabet, A., George, K., Roberts, L., Carne, R., Blum, S., Henderson, R., Van Damme, P., Demeestere, J., Larue, S., D'Amour, C. ... Zwolińska, G. (2019). Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies. Journal of the Peripheral Nervous System, 24 (1), 48-55. doi: 10.1111/jns.12302 |
|
2018 Journal Article Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosisPender, Michael P., Csurhes, Peter A., Smith, Corey, Douglas, Nanette L., Neller, Michelle A., Matthews, Katherine K., Beagley, Leone, Rehan, Sweera, Crooks, Pauline, Hopkins, Tracey J., Blum, Stefan, Green, Kerryn A., Ioannides, Zara A., Swayne, Andrew, Aftab, Blake T., Hooper, Kaye D., Burrows, Scott R., Thompson, Kate M., Coulthard, Alan and Khanna, Rajiv (2018). Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis. JCI Insight, 3 (22) e124714. doi: 10.1172/jci.insight.124714 |
|
2018 Journal Article Refractory epilepsy secondary to anti-GAD encephalitis treated with DBS post SEEG evaluation: a novel case report based on stimulation findingsGillinder, Lisa, Lehn, Alexander, Papacostas, Jason, Olson, Sarah, Blum, Stefan and Dionisio, Sasha (2018). Refractory epilepsy secondary to anti-GAD encephalitis treated with DBS post SEEG evaluation: a novel case report based on stimulation findings. Epileptic Disorders, 20 (5), 451-456. doi: 10.1684/epd.2018.0993 |
|
2018 Journal Article A case of immune-mediated encephalitis related to daclizumab therapyDevlin, Michael, Swayne, Andrew, Newman, Martin, O'Gorman, Cullen, Brown, Helen, Ong, Benjamin, Robertson, Thomas, Airey, Caroline and Blum, Stefan (2018). A case of immune-mediated encephalitis related to daclizumab therapy. Multiple Sclerosis Journal, 25 (5), 750-753. doi: 10.1177/1352458518792403 |
|
2018 Journal Article Genome-wide association study in Guillain-Barré syndromeBlum, Stefan, Ji, Ying, Pennisi, David, Li, Zhixiu, Leo, Paul, McCombe, Pamela and Brown, Matthew A. (2018). Genome-wide association study in Guillain-Barré syndrome. Journal of Neuroimmunology, 323, 109-114. doi: 10.1016/j.jneuroim.2018.07.016 |
|
2018 Journal Article Testing for antibodies to N-methyl-d-aspartate receptor and other neuronal cell surface antigens in patients with early psychosisScott, James G., Gillis, David, Swayne, Andrew and Blum, Stefan (2018). Testing for antibodies to N-methyl-d-aspartate receptor and other neuronal cell surface antigens in patients with early psychosis. The Australian and New Zealand Journal of Psychiatry, 52 (8), 727-729. doi: 10.1177/0004867418782421 |
|
2018 Journal Article Anti-glycine receptor antibody related disease: a case series and literature reviewSwayne, Andrew, Tjoa, Linda, Broadley, Simon, Dionisio, Sasha, Gillis, David, Jacobson, Leslie, Woodhall, Mark R, McNabb, Andrew, Schweitzer, Daniel, Tsang, Ben, Vincent, Angela, Irani, Sarosh R, Wong, Richard, Waters, Patrick and Blum, Stefan (2018). Anti-glycine receptor antibody related disease: a case series and literature review. European Journal of Neurology, 25 (10), 1290-1298. doi: 10.1111/ene.13721 |
|
2018 Journal Article Intravenous versus subcutaneous immunoglobulin – Authors' replyvan Schaik, Ivo N, Mielke, Orell, Sabet, Arman, George, Koshy, Roberts, Leslie, Carne, Ross, Blum, Stefan, Henderson, Robert, Van Damme, Philip, Demeestere, Jelle, Larue, Sandrine, Pinard D'Amour, Catherine-Andree, Bril, Vera, Breiner, Ari, Kunc, Pavel, Valis, Martin, Sussova, Jana, Kalous, Tomas, Talab, Radomir, Bednar, Michal, Toomsoo, Toomas, Rubanovits, Inna, Gross-Paju, Katrin, Sorro, Ulvi, Saarela, Mika, Auranen, Mari, Pouget, Jean, Attarian, Shahram, Le Masson, Gwendal ... Mielke, Orell (2018). Intravenous versus subcutaneous immunoglobulin – Authors' reply. The Lancet Neurology, 17 (5), 393-394. doi: 10.1016/S1474-4422(18)30109-1 |
|
2018 Journal Article The prevalence and treatment outcomes of antineuronal antibody-positive patients admitted with first episode of psychosisScott, James, G., Gillis, David, Ryan, Alex, E., Hargovan, Hethal, Gundarpi, Nagaraj, McKeon, Gemma, Hatherill, Sean, Newman, Martin P., Parry, Peter, Prain, Kerri, Patterson, Sue, Wong, Richard, C. W., Wilson, Robert, J. and Blum, Stefan (2018). The prevalence and treatment outcomes of antineuronal antibody-positive patients admitted with first episode of psychosis. BJ Psych Open, 4 (2), 69-74. doi: 10.1192/bjo.2018.8 |
|
2018 Journal Article Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trialvan Schaik, Ivo N., Bril, Vera, van Geloven, Nan, Hartung, Hans-Peter, Lewis, Richard A., Sobue, Gen, Lawo, John-Philip, Praus, Michaela, Mielke, Orell, Durn, Billie L., Cornblath, David R., Merkies, Ingemar S. J., Sabet, A., George, K., Roberts, L., Carne, R., Blum, S., Henderson, R., Van Damme, P., Demeestere, J., Larue, S., D'Amour, C., Bril, V., Breiner, A., Kunc, P., Valis, M., Sussova, J., Kalous, T., Talab, R. ... on behalf of the PATH study group (2018). Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Neurology, 17 (1), 35-46. doi: 10.1016/S1474-4422(17)30378-2 |
|
2017 Journal Article Legionella longbeachae pneumonia as a complication of alemtuzumab therapyBoyle, S., Olive, G., Townell, N., Henderson, A., Bowler, S. and Blum, S. (2017). Legionella longbeachae pneumonia as a complication of alemtuzumab therapy. Journal of Clinical Neuroscience, 46, 67-69. doi: 10.1016/j.jocn.2017.08.051 |
